Impact Factor (ICV) 6.79, NAAS Rating: 5.03 | Free Publication Certificate | NAAS Rating: 5.03
NAAS Rating: 5.03
UGC Approved Journal
"The Pharma Innovation" (TPI) is not responsible for the content of individual manuscripts. All reasonable precautions have been taken by the authors, editors and publishers to verify drug names and doses, the results of experimental work and the clinical findings published in this journal. The opinions expressed are those of the authors, and not necessarily those of the editors or publishers. The ultimate responsibility for the use of information mentioned in the Journal lies with whoever uses it, and the editors and publishers can accept no liability whatsoever in respect of any claim for damages arising therefrom. Please inform the editors of any errors.
Neither "The Pharma Innovation" nor its publishers nor anyone else involved in creating, producing or delivering the Journal or the materials contained therein, assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the Journal nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of "The Pharma Innovation".
This publication is provided "as is" without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. Descriptions of, or references to, products or publications does not imply endorsement of that product or publication.
"The Pharma Innovation" contains links to other journals and web sites operated by other parties. These links are provided purely as educational purpose. Such links do not imply TPI's endorsement of material on any other site and "The Pharma Innovation" disclaims all liability with regard to your access of such linked web sites.